UNSPSC 51461526: Saw palmetto

This classification denotes a natural product which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J7WWH9M8QS, which the Integrated Taxonomic Information System classifies under Taxonomic Serial Number 42508 as a member of Kingdom Plantae, Subkingdom Viridaeplantae, Infrakingdom Streptophyta, Division Tracheophyta, Subdivision Spermatophytina, Infradivision Angiospermae, Class Magnoliopsida, Superorder Lilianae (monocots), Order Arecales, Family Arecaceae, Genus Serenoa Hook. f. (serenoa), Species Serenoa repens, commonly known as SAW PALMETTO.

UNSPSC 51461526 Saw palmetto is a Commodity code that captures herbal and botanical supplement products, though recent state and local procurement activity under this code reflects broader pharmaceutical and over-the-counter product aggregation rather than single-ingredient sourcing. State and local governments are purchasing these products through cooperative purchasing vehicles that bundle generic pharmaceuticals, OTC medicines, and supplement lines to standardize pricing and supply across multiple jurisdictions. The issuing bodies include state procurement offices and multistate cooperative purchasing alliances that procure on behalf of participating state agencies, counties, municipalities, and other public facilities. Vendors must comply with FDA manufacturing standards, maintain cGMP certification and DSCSA compliance, and hold adequate insurance coverage including commercial general liability of $5,000,000 per occurrence and network security and privacy liability of $2,000,000.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued a Request for Proposal (S1070000015802) on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products, with a response deadline of March 26, 2026. The procurement covers participating states including Minnesota and Oregon, with awarded vendors required to supply through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and to maintain contractual relationships with at least two of the three. The RFP weights price competitiveness at 75 percent of the evaluation, with fixed pricing (10 percent), EDI capability (5 percent), administrative fee compliance (5 percent), and data format compliance (5 percent) making up the remainder. The contract term is two years for new responders with optional extensions at MMCAP's discretion, and vendors must agree to a 3 percent administrative fee on all purchases with performance penalties ranging from $200 to $1,500 per violation.